Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

Antimicrobial resistance: global problems need global solutions

Much has been written about antimicrobial resistance and the measures we must take to prevent an era in which infections become untreatable. Despite these longstanding concerns, there has been a steady rise in antimicrobial resistance globally, threatening the effectiveness of increasing numbers of antimicrobial classes against broadening species of microorganisms.

Do we continue on our current path until no effective antimicrobials are available, the pressure on microorganisms is slowly reduced, and resistance wanes over time? If so, we face a period during which many people will die with untreatable infections. Or do we act now?

In the spirit of optimism that action now can still make a difference, we publish in this issue several articles to be presented at this week’s combined Australasian Society for Infectious Diseases (ASID) and Communicable Disease Control conference, which address the breadth of antimicrobial resistance issues we currently face.

In their editorial, Looke and colleagues from the ASID Council (doi: 10.5694/mja13.10190) describe the growing threat of multiresistant…